BioPharmX Corporation (NYSE American: BPMX) (“BioPharmX”) announced Wednesday that all proposals related to its proposed merger with Timber Pharmaceuticals LLC (“Timber”) were approved by BioPharmX’s stockholders at a special meeting held on May 13, 2020. The proposed merger remains subject to further customary closing conditions and regulatory approvals. BioPharmX and Timber expect the closing of the merger to occur on or about May 18, 2020. Upon closing of the transaction, the combined company will change its name to “Timber Pharmaceuticals, Inc.” and it is anticipated that the shares will commence trading on the NYSE American market under the ticker symbol “TMBR.”
Read the full article: BioPharmX Corporation Announces Approval of Merger by Stockholders //
Source: https://www.prnewswire.com/news-releases/biopharmx-corporation-announces-approval-of-merger-by-stockholders-at-special-meeting-301058862.html